Gelesis announced today that it partnered with China Medical Systems for the commercialization of the Plenity weight loss pill in China. Under the terms of the deal, CMS will provide $35 million upfront via licensing fees and equity investment, plus there remains the potential for an additional $388 million in future milestone payments, as well […]